 WALTHAM, Mass., Nov. 04, 2022 GLOBE NEWSWIRE -- Xilio Therapeutics, Inc. Nasdaq: XLO, a biotechnology company developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that the company will participate in a virtual fireside chat at the Cowen 6th Annual IO Next Summit on Friday, November 11, 2022, at 1:40 p.m. ET. 